Programme

Overview: This clinical skin cancer symposium presents evidence-based guidance for the management of high-risk non-melanoma skin cancer with examination of decision making strategies utilised in the clinic, along with review of the impact of novel genomic staging compared to currently available guidance. High-risk non-melanoma skin cancers develop the older patient population and strategies to measure the cosmetic and quality of life effects of treatment are described, sharing these tools enables radiation oncologists to help patients make informed decisions regarding their care.

Overview: Positioning the patient in an upright position has been investigated since the early beginnings of radiotherapy. Recently, it has enjoyed a surge in interest sparked by academic publications and commercial solutions for upright positioning systems and associated image guidance. The list of potential benefits is manifold: Reduced cost and more compact treatment facilities especially for proton therapy; for heavy ion therapy upright treatments would unlock flexibility in terms of available field angles; CT or eventually even MR imaging at the treatment isocenter would become possible; upright positioning could also improve patient comfort. In this session not only the potential benefits and the current status of Upright RT will be presented, but also its challenges and required real-world feasibility proof for clinical translation will be discussed. From the talks approaching the topic from different perspectives, you should be in a good position to appraise for yourself, if Upright RT is rather a hype or a hope.

Overview: With rapid technological development it is interesting to see how fast and to what extent we can transfer the ongoing research into clinical practice in Radiotherapy. We will tackle this challenge with short presentations from four different perspectives followed by a group discussion. The presented topics will cover a variety of areas such as how to connect preclinical research and clinical practice, the possibilities of the application of emerging new technologies like AI, the manners to personalize radiation and radio-immuno-therapies, the ways to organize and coordinate the interdisciplinary work and collaborations for translational studies on different levels and many more.

Overview: Mini-Orals are presented at one of the sessions scheduled in the two mini-oral theatres. Each author will present a 4-slide PowerPoint orally for 4 minutes, followed by 3 minutes for discussion. Sessions will not be recorded.

Overview: Mini-Orals are presented at one of the sessions scheduled in the two mini-oral theatres. Each author will present a 4-slide PowerPoint orally for 4 minutes, followed by 3 minutes for discussion. Sessions will not be recorded.

Overview: Poster Discussions are presented in one of the sessions scheduled at the two poster discussion theatres. Each author will present a digital poster orally for 2 minutes, followed by 2 minutes for discussion. Sessions will not be recorded.

Overview: Poster Discussions are presented in one of the sessions scheduled at the two poster discussion theatres. Each author will present a digital poster orally for 2 minutes, followed by 2 minutes for discussion. Sessions will not be recorded.

Overview: Proffered Papers are presented in one of the sessions scheduled in the main session halls. Each author will present orally for 7 minutes, followed by 3 minutes for discussion. Sessions will be recorded and available on-demand.